StockWatch
·
Agricultural Chemicals
Management ChangeMay 13, 2026, 06:07 AM

SenesTech Appoints Michael Edell as New CEO; Q1 Revenue Up 2%

AI Summary

SenesTech, Inc. announced a significant management change with Michael Edell appointed as the new President and CEO, succeeding Joel Fruendt. For the first quarter of 2026, the company reported a 2% increase in net revenues to $493,000, primarily driven by its Evolve product line, which now constitutes 85% of total revenues. Despite an 8% increase in gross profit to $338,000, the net loss widened by 24% to $(2,063,000) due to increased operating expenses. The company also settled its legal dispute with Liphatech Inc. in March 2026.

Key Highlights

  • Michael Edell appointed President and CEO of SenesTech, succeeding Joel Fruendt, effective May 6, 2026.
  • Net revenues for Q1 2026 increased 2% to $493,000 compared to Q1 2025.
  • Net loss for Q1 2026 widened 24% to $(2,063,000) from $(1,665,000) in Q1 2025.
  • Gross profit for Q1 2026 increased 8% to $338,000, with a margin of 68.6%.
  • Cash and cash equivalents were $6.8 million as of March 31, 2026.
  • Evolve product line represented 85% of Q1 2026 revenues, up from 79% in Q1 2025.
  • The lawsuit with Liphatech Inc. was settled in March 2026.